ANRO Competitors & Alternatives
Compare Alto Neuroscience, Inc. with similar stocks in the same industry
Biotechnology
ANRO
Main Stock$23.32
Tradestie Score
71
Market Cap
$110.20M
Analyst Upside
+66.7%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MDXG
MiMedx Group, Inc
|
$3.74
|
$1.01B | 105.8 | 49 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.81
|
$996.55M | - | 48 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$92.95
|
$994.20M | - | 38 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.56
|
$993.46M | - | 57 | Compare |
|
IMNM
Immunome, Inc.
|
$18.00
|
$987.09M | - | 63 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$2.35
|
$951.83M | - | 60 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$28.08
|
$931.48M | - | 57 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.41
|
$917.23M | - | 58 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$17.91
|
$906.29M | - | 55 | Compare |
More ANRO Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry